(-0.58%) 5 022.21 points
(-0.12%) 37 753 points
(-1.15%) 15 683 points
(-2.88%) $82.90
(-1.04%) $1.714
(-0.81%) $2 388.30
(-0.04%) $28.37
(-2.25%) $953.30
(-0.49%) $0.937
(0.19%) $11.00
(-0.22%) $0.803
(-0.05%) $94.10
Live Chart Being Loaded With Signals
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions...
Stats | |
---|---|
Today's Volume | 59 225.00 |
Average Volume | 48 096.00 |
Market Cap | 93.11M |
EPS | SEK0 ( 2024-02-28 ) |
Next earnings date | ( SEK0 ) 2024-04-26 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -1.450 |
ATR14 | SEK0.0890 (1.12%) |
Iconovo AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Iconovo AB (publ) Financials
Annual | 2023 |
Revenue: | SEK7.08M |
Gross Profit: | SEK-53.81M (-760.26 %) |
EPS: | SEK-4.39 |
Q4 | 2023 |
Revenue: | SEK968 000 |
Gross Profit: | SEK-11.23M (-1 160.23 %) |
EPS: | SEK-0.950 |
Q3 | 2023 |
Revenue: | SEK3.18M |
Gross Profit: | SEK4.48M (140.80 %) |
EPS: | SEK-0.970 |
Q2 | 2023 |
Revenue: | SEK2.62M |
Gross Profit: | SEK5.16M (196.91 %) |
EPS: | SEK-1.280 |
Financial Reports:
No articles found.
Iconovo AB (publ)
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius AB (publ) to develop inhalation product to treat COPD. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators